Complement genetics, deficiencies, and disease associations

Abstract

The complement system is a key component of innate immunity. More than 45 genes encoding the proteins of complement components or their isotypes and subunits, receptors, and regulators have been discovered. These genes are distributed throughout different chromosomes, with 19 genes comprising three significant complement gene clusters in the human genome. Genetic deficiency of any early component of the classical pathway (C1q, C1r/s, C2, C4, and C3) is associated with autoimmune diseases due to the failure of clearance of immune complexes (IC) and apoptotic materials, and the impairment of normal humoral response. Deficiencies of mannan-binding lectin (MBL) and the early components of the alternative (factor D, properdin) and terminal pathways (from C3 onward components: C5, C6, C7, C8, C9) increase susceptibility to infections and their recurrence. While the association of MBL deficiency with a number of autoimmune and infectious disorders has been well established, the effects of the deficiency of other lectin pathway components (ficolins, MASPs) have been less extensively investigated due to our incomplete knowledge of the genetic background of such deficiencies and the functional activity of those components. For complement regulators and receptors, the consequences of their genetic deficiency vary depending on their specific involvement in the regulatory or signalling steps within the complement cascade and beyond. This article reviews current knowledge and concepts about the genetic load of complement component deficiencies and their association with diseases. An integrative presentation of genetic data with the latest updates provides a background to further investigations of the disease association investigations of the complement system from the perspective of systems biology and systems genetics.

Keywords

complement system / deficiency / disease association / HLA-III / RCA

References

[1] Agnello, V., De Bracco, M.M., and Kunkel, H.G. (1972). Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus. J Immunol 108, 837-840 .
[2] Alper, C.A., and Propp, R.P. (1968). Genetic polymorphism of the third component of human complement (C'3). J Clin Invest 47, 2181-2191 .10.1172/JCI105904
[3] Azen, E.A., and Smithis, O. (1968). Genetic polymorphism of C'3(beta1C-globulin) in human serum. Science 162, 905-907 .10.1126/science.162.3856.905
[4] Bernard Cher, T.H., Chan, H.S., Klein, G.F., Jabkowski, J., Schadenb?ck- Kranzl, G., Zach, O., Roca, X., and Law, S.K. (2011). A novel 30 splice-site mutation and a novel gross deletion in leukocyte adhesion deficiency (LAD)-1. Biochem Biophys Res Commun 404, 1099-1104 .10.1016/j.bbrc.2010.12.124
[5] Blanchong, C.A., Chung, E.K., Rupert, K.L., Yang, Y., Yang, Z., Zhou, B., Moulds, J.M., and Yu, C.Y. (2001). Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4. Int Immunopharmacol 1, 365-392 .10.1016/S1567-5769(01)00019-4
[6] Bracho, F.A. (2005). Hereditary angioedema. Curr Opin Hematol 12, 493-498 .10.1097/01.moo.0000179805.57486.4e
[7] Butko, P., Nicholson-Weller, A., and Wessels, M.R. (1999). Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus. J Immunol 163, 2761-2768 .
[8] Carroll, M.C. (2004). The complement system in regulation of adaptive immunity. Nat Immunol 5, 981-986 .10.1038/ni1113
[9] Cortes, A., and Brown, M.A. (2011). Promise and pitfalls of the Immunochip. Arthritis Res Ther 13, 101.10.1186/ar3204
[10] Dahl, M., Tybjaerg-Hansen, A., Schnohr, P., and Nordestgaard, B.G. (2004). A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J Exp Med 199, 1391-1399 .10.1084/jem.20040111
[11] Davies, E.J., The, L.S., Ordi-Ros, J., Snowden, N., Hillarby, M.C., Hajeer, A., Donn, R., Perez-Pemen, P., Vilardell-Tarres, M., and Ollier, W.E. (1997). A dysfunctional allele of the mannose binding protein gene associates with systemic lupus erythematosus in a Spanish population. J Rheumatol 24, 485-488 .
[12] Day, N.K., Geiger, H., McLean, R., Michael, A., and Good, R.A. (1973). C2 deficiency. Development of lupus erythematosus. J Clin Invest 52, 1601-1607 .10.1172/JCI107337
[13] Degn, S.E., Jensenius, J.C., and Thiel, S. (2011) Disease-causing mutations in genes of the complement system. Am J Hum Genet 88, 689-705 .10.1016/j.ajhg.2011.05.011
[14] Endo, Y., Takahashi, M., and Fujita, T. (2006). Lectin complement system and pattern recognition. Immunobiol 211, 283.10.1016/j.imbio.2006.01.003
[15] Figueroa, J.E., and Densen, P. (1991). Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 4, 359-395 .
[16] Garcia-Laorden, M.I., Sole-Violan, J., Rodriguez de Castro, F., Aspa, J., Briones, M.L., Garcia-Saavedra, A., Rajas, O., Blanquer, J., Caballero-Hidalgo, A., Marcos-Ramos, J.A., . (2008). Mannose- binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults. Allergy Clin Immunol 122, 368-374 .10.1016/j.jaci.2008.05.037
[17] Garred, P., Honoré, C., Ma, Y.J., R?rvig, S., Cowland, J., Borregaard, N., and Hummelsh?j, T. (2010) The genetics of ficolins. J Innate Immun 2, 3-16 .10.1159/000242419
[18] Garred, P., Madsen, H.O., Hofmann, B, and Svejgaard, A. (1995). Increased frequency of homozygosity of abnormal mannan- binding-protein alleles in patients with suspected immunodeficiency. Lancet 346, 941-943 .10.1016/S0140-6736(95)91559-1
[19] Gerard, N.P., and Gerard, C. (1991). The chemotactic receptor for human C5a anaphylatoxin. Nature 349, 614-617 .10.1038/349614a0
[20] Glesse, N., Monticielo, O.A., Mattevi, V.S., Brenol, J.C., Xavier, R.M., da Silva, G.K., Dos Santos, B.P., Rucatti, G.G., and Chies, J.A. (2011). Association of mannose-binding lectin 2 gene polymorphic variants with susceptibility and clinical progression in systemic lupus erythematosus. Clin Exp Rheumatol 29, 983-990 .
[21] Graudal, N.A., Homann, C., Madsen, H.O., Svejgaard, A., Jurik, A.G., Graudal, H.K., and Garred, P. (1998). Mannan binding lectin in rheumatoid arthritis. A longitudinal study. J Rheumatol 25, 629-635 .
[22] Heitzeneder, S., Seidel, M., F?rster-Waldl, E., and Heitger, A. (2012). Mannan-binding lectin deficiency- Good news, bad news, doesn't matter? Clin Immunol 143, 22-38 .10.1016/j.clim.2011.11.002
[23] Hohler, T., Stradmann-Bellinghausen, B., Starke, R., Sanger, R., Victor, A., Rittner, C, and Schneider, P.M. (2002). C4A deficiency and nonresponse to hepatitis B vaccination. J Hepatol 37, 387-392 .10.1016/S0168-8278(02)00205-2
[24] Imbasciati, E., Bucci, R., Barbisoni, F., Borlandelli, S., Corradi, B., Cosci, P., Farina, M., and Mandolfo, S. (2003). Acute renal failure and thrombotic microangiopathy. G Ital Nefrol 20, 285-297 .
[25] Karp, C.L., Wysocka, M., Wahl, L.M., Ahearn, J.M., Cuomo, P.J., Sherry, B., Trinchieri, G., and Griffin, D.E. (1996). Mechanism of suppression of cell-mediated immunity by measles virus. Science 273, 228-231 .10.1126/science.273.5272.228
[26] Krarup, A., Sorensen, U.B., Matsushita, M., Jensenius, J.C., and Thiel S. (2005). Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan- binding lectin, L-ficolin, and H-ficolin. Infect Immun 73, 1052-1060 .10.1128/IAI.73.2.1052-1060.2005
[27] Kraus, D.M., Elliott, G.S., Chute, H., Horan, T., Pfenninger K.H., Sanford, SD., Foster, S., Scully, S., Welcher, A.A., and Holers, V.M. (2006). CSMD1 is a novel multiple domain complementregulatory protein highly expressed in the central nervous system and epithelial tissues. J Immunol 176, 4419-4430 .
[28] Laich, A., and Sim, R.B. (2001). Cross-talk between the human complement classical and alternative pathways: evidence for a C4bBb 'hybrid' C3 convertase. Mol Immunol 38, 105.
[29] Langer, H.F., Chung, K.J., Orlova, V.V., Choi, E.Y., Kaul, S., Kruhlak, M.J., Alatsatianos, M., Deangelis, R.A., Roche, P.A., Magotti, P., . (2010). Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood 116, 4395-4403 .10.1182/blood-2010-01-261503
[30] Law, S.K.A., and Reid, K.B.M. (1995). Complement (Oxford: IRL Press at Oxford University Press).
[31] Linton, S. (2001). Animal models of inherited complement deficiency. Mol Biotechnol 18, 135-148 .10.1385/MB:18:2:135
[32] Martiny, F.L., Veit, T.D., Brenol, C.V., Brenol, J.C., Xavier, R.M., Bogo, M.R., and Chies, J.A. (2012). Mannose-binding lectin gene polymorphisms in Brazilian patients with rheumatoid arthritis. J Rheumatol 39, 6-9 .10.3899/jrheum.110052
[33] Mayilyan, K.R., Kang, Y.H., Dodds, A.W., and Sim, R.B. (2008). The complement system in innate immunity. In Innate Immunity of Plants, Animals and Humans (Series: Nucleic Acids and Molecular Biology, Vol. 21) , H. Heine, ed. (Heidelberg: Springer) , pp. 219-236 .
[34] Mayilyan, K.R., Schneider, P.M., Hartmann, A., H?hnel, P.S., Stradmann- Bellinghausen, B., M?ller, H.J., Soghoyan, A.F., Rujescu, D., and Sim, R.B. (2012). Complement C4 genes in schizophrenia: a study using a new genotyping approach to RP-C4-CYP21-TNX unit screening (in press).
[35] Mayilyan, K.R., and Weinberger, D.R. (2008). Involvement of the HLA genetic diversity in schizophrenia: supporting data and perspectives. ASHI Quarterly (The American Society of Histocompatibility and Immunogenetics) 32, 74-80 .
[36] Mayilyan, K.R., Weinberger, D.R., Wu, Y.L., Kolachana, B., McBride, K., and Yung, C.Y. (2007). Association of complement C4B gene deficiency with schizophrenia: studies of European American families and controls. Abstracts of XV World Congress on Psychiatric Genetics, 7-11 October, 2007, New York, NY, USA , P109.
[37] Munthe-Fog, L., Hummelsh?j, T., Honoré, C., Madsen, H.O., Permin, H., and Garred, P. (2009). Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. N Engl J Med 360, 2637-2644 .10.1056/NEJMoa0900381
[38] Nagase, T., Kikuno, R., and Ohara, O. (2001). Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins. DNA Res 8, 179-187 .10.1093/dnares/8.4.179
[39] Ohi, H., Ikezawa, T., Watanabe, S., Seki, M., Mizutani, Y., Nawa, N., and Hatano, M. (1986). Two cases of mesangiocapillary glomerulonephritis with CR1 deficiency. Nephron 43, 307.10.1159/000183861
[40] Petersen, S.V., Thiel, S., and Jensenius, J.C. (2001). The mannan- binding lectin pathway of complement activation: biology and disease association. Mol Immunol 38, 133-149 .10.1016/S0161-5890(01)00038-4
[41] Pickering, M.C., Botto, M., Taylor, P.R., Lachmann, P.J., and Walport, M.J. (2000). Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76, 227-324 .10.1016/S0065-2776(01)76021-X
[42] Rahpeymai, Y., Hietala, M.A., Wilhelmsson, U., Fotheringham, A., Davies, I., Nilsson, A.K., Zwirner, J., Wetsel, R.A., Gerard, C., Pekny, M., . (2006). Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J 25, 1364-1374 .10.1038/sj.emboj.7601004
[43] Reid, K.B.M., Bentley, D.R., Campbell, R.D., Chung, L.P., Sim, R.B., Kristensen, T., and Tack, B.F. (1986). Complement-system proteins which interact with C3B or C4B – A superfamily of structurally related proteins. Immunol Today 7, 230-234 .10.1016/0167-5699(86)90110-6
[44] Reis, S.E., Falcao, D.A., and Isaac, L. (2006). Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H. Scand J Immunol 63, 155-168 10.1111/j.1365-3083.2006.01729.x
[45] Ricklin, D., Hajishengallis, G., Yang, K., and Lambris, J.D. (2010). Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11, 785-797 .10.1038/ni.1923
[46] Roos, D., Meischl, C., de Boer, M., Simsek, S., Weening, R.S., Sanal, O., Tezcan, I., Güng?r, T., and Law, S.K. (2002). Genetic analysis of patients with leukocyte adhesion deficiency: genomic sequencing reveals otherwise undetectable mutations. Exp Hematol 30, 252-261 .10.1016/S0301-472X(01)00782-2
[47] Schneider, P.M., Witzel-Schl?mp, K., Rittner, C., and Zhang, L. (2001). The endogenous retroviral insertion in the human complement C4 gene modulates the expression of homologous genes by antisense inhibition. Immunogenetics 53, 1-9 .10.1007/s002510000288
[48] Schneider, P.M., and Wurzner, R. (1999). Complement genetics: biological implications of polymorphisms and deficiencies. Immunol Today 20, 2-5 .10.1016/S0167-5699(98)01375-9
[49] Sim, R.B., and Malhotra, R. (1994). Interactions of carbohydrates and lectins with complement. Biochem Soc Trans 22, 106-111 .
[50] Sim, R.B., Clark, H., Hajela, K., and Mayilyan, K.R. (2006). Collectins and host defence. Novartis Found Symp 279, 170-181 .10.1002/9780470035399.ch14
[51] Sim, R.B., Moffatt, B.E., Shaw, J.M., and Ferluga J. (2008). Complement control proteins and receptors: from FH to CR4. In Molecular Aspects of Innate and Adaptive Immunity , K.B.M. Reid, and R.B. Sim, eds (Cambridge, UK: RSC Publishing), pp. 84-104 .
[52] Sjoholm, A.G. (2002). Deficiencies of mannan-binding lectin, the alternative pathway, and the late complement components. In Manual of Clinical Laboratory Immunology , 6th ed, N.R. Rose, R.G. Hamilton, B. Detrick, eds. (Washington, DC: ASM Press) pp.847-854 .
[53] Sjoholm, A.G., Jonsson, G., Braconier, J.H., Sturfelt, G., and Truedsson, L. (2006). Complement deficiency and disease: an update. Mol Immunol 43, 78-85 .10.1016/j.molimm.2005.06.025
[54] Skerka C., Lauer N., Weinberger A.A., Keilhauer C.N., Sühnel J., Smith R., Schl?tzer-Schrehardt U., Fritsche L., Heinen S., Hartmann A., . (2007). Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. Mol Immuno 44, 3398-3406 .10.1016/j.molimm.2007.02.012
[55] Springer, T.A., Thompson, W.S., Miller, L.J., Schmalstieg, F.C., and Anderson, D.C. (1984). Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis. J Exp Med 160, 1901-1918 .10.1084/jem.160.6.1901
[56] Springer, T.A., Miller, L.J., and Anderson, D.C. (1986). p150,95, the third member of the Mac-1, LFA-1 human leukocyte adhesion glycoprotein family. J Immun 136, 240-245 .
[57] Stengaard-Pedersen, K., Thiel, S., Gadjeva, M., Moller-Kristensen, M., Sorensen, R., Jensen, L.T., Sjoholm, A.G., Fugger, L., and Jensenius, J.C. (2003). Inherited deficiency of mannan-binding lectin-associated serine protease 2. N Engl J Med 349, 554-560 .10.1056/NEJMoa022836
[58] Stevens, B., Allen, N.J., Vazquez, L.E., Howell, G.R., Christopherson, K.S., Nouri, N., Micheva, D., Mehalow, A.K., Huberman, A.D., Stafford, B., . (2007). The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164-1178 .10.1016/j.cell.2007.10.036
[59] Sullivan, K.E., Wooten, C., Goldman, D., and Petri, M. (1996). Mannose- binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum 39, 2046-2051 .10.1002/art.1780391214
[60] Sumiya, M., Super. M., Tabona, P., Levinsky, R.J., Arai, T., Turner, M.W., and Summerfield, J.A. (1991). Molecular basis of opsonic defect in immunodeficient children. Lancet 337, 1569-1570 .10.1016/0140-6736(91)93263-9
[61] Summerfield, J.A., Sumiya, M., Levin, M., and Turner, M.W. (1997). Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 314, 1229-1232 .10.1136/bmj.314.7089.1229
[62] Super M., Thiel S., Lu J., Levinsky R.J., and Turner M.W. (1989). Association of low levelsn of mannan-binding protein with a common defect of opsonisation. Lancet . 2, 1236-1239 .10.1016/S0140-6736(89)91849-7
[63] Takeda, J., Miyata, T., Kawagoe, K., Iida, Y., Endo, Y., Fujita, T., Takahashi, M., Kitani, T., and Kinoshita, T. (1993). Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73, 703-711 .10.1016/0092-8674(93)90250-T
[64] Tarr, J., and Eggleton, P. (2005). Immune function of C1q and its modulators CD91 and CD93. Crit Rev Immunol 25, 305-330 .10.1615/CritRevImmunol.v25.i4.40
[65] Turner, M.W. (2003). The role of mannose-binding lectin in health and disease. Mol Immunol 40, 423-429 .10.1016/S0161-5890(03)00155-X
[66] Turner, M.W., and Hamvas, R.M. (2000). Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2, 305-322 .
[67] Vorup-Jensen, T., Petersen, S.V., Hansen, A.G., Poulsen, K., Schwaeble, W., Sim, R.B., Reid, K.B., Davis, S.J., Thiel, S., and Jensenius, J.C. (2000). Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease- 2. J. Immunology 165, 2093-2100 .
[68] Yang, Y., Chung, E.K., Zhou, B., Lhotta, K., Hebert, L.A., Birmingham, D.J., Rovin, B.H., and Yu, C.Y. (2004). The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun 7, 98-132 10.1159/000075689
[69] Yang, Z., Mendoza, A.R., Welch, T.R., Zipf, W.B., and Yu, C.Y. (1999). Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module). A mechanism for gene deletions and disease associations. J Biol Chem 274, 12147-12156 .10.1074/jbc.274.17.12147
[70] Yu, C.Y., Chung, E.K., Yang, Y., Blanchong, C.A., Jacobsen, N., Saxena, K., Yang, Z., Miller, W., Varga, L., and Fust, G. (2003). Dancing with complement C4 and the RP-C4-CYP21-TNX (RCCX) modules of the major histocompatibility complex. Prog Nucleic Acid Res Mol Biol 75, 217-292 .10.1016/S0079-6603(03)75007-7